Form D · Venture Capital Fund
AVSF - Precision Neuroscience 2026, LLC
Boston, MA · CIK 0002153020
Offering snapshot reported Oct 13, 2026 · SEC filing
- Reported sold
- $1.04M Indefinite offering
- Investors reported
- 58 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Oct 1, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 13, 2026 | Initial | $1,035,800 | No comparison | 58 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-600948
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Oct 13, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Collins | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
70 Federal Street 6th Floor
Boston, MA, 02110
Boston, MA, 02110